[18F]NIDF PET Imaging in Tau-related Diseases

Exclusion Criteria

• •1. Has allergy to \[18F\]NIDF or any of its excipients;
• •2. Incapable of providing written informed consent or lacking a legally authorized representative (LAR) to provide informed consent ;
• •3. Unwilling or unable to undergo PET scans tracer injections;
• •4. Any condition that, in the Investigator's opinion, could increase the risk to the participant, limit the participant's ability to tolerate the research procedures, or interfere with the collection/analysis of the data (e.g., renal or liver failure, advanced cancer);
• •5. Received an experimental drug or device within 1 month (whose efficacy or safety is unclear);
• •6. Have other serious neurological disorders, or gastrointestinal, cardiovascular, liver, kidney, blood system, tumor, endocrine, respiratory, immune deficiency, and other serious diseases;
• •7. Women who are currently pregnant or breastfeeding.